Inventor · disambiguated record
Dirk Hoerstermann
Also filed as: HOERSTERMANN DIRK
1 granted patent·3 pending applications·1 citations·filing 2010–2016
17Inventor score
Technology areasA61P
Files withBOEHRINGER INGELHEIM VETMED1BOEHRINGER INGELHEIM VETMEDICA GMBH1DE VRIES FRERICH1NAGEL NORBERT1
Top patents by PatentIndex Score
4 records- 0158US9056833B2Crystalline phases of 2′-{[2-(4-methoxy-phenyl)-acetylamino]-methyl}-biphenyl-2-carboxylic acid (2-pyridin-3-yl-ethyl)-amideNAGEL NORBERT·Filed 2010·Granted Jun 16, 2015·1 cites·8 claims
- 0249US2014228287A11-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-axanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animalDE VRIES FRERICH·Filed 2014·Application pending·0 cites
- 0344US2011237532A11-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-xanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animalBOEHRINGER INGELHEIM VETMED·Filed 2011·Application pending·0 cites
- 0444US2016346288A11-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-xanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animalBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →